Sherif Shaaban, MBBCH, MSC
Radiation Oncology
Highlights
Johns Hopkins Affiliations:
- Johns Hopkins School of Medicine Faculty
About Sherif Shaaban
Primary Academic Title
Instructor in Radiation Oncology and Molecular Radiation Sciences
Background
Dr. Sherif Shaaban is a radiation oncologist at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington DC. Dr. Shaaban has expertise in treating hematologic malignancies (blood cancers), kidney cancers, and oligometastatic disease.
He uses the latest treatment options in proton and conventional radiation therapy, developing plans that precisely treat each person’s individual cancer and providing a tailored approach to care.
Dr. Shabaan has a bit of extra experience which adds a breadth and depth to his clinical knowledge and experience and speaks to his determination. He originally hails from Egypt and had completed a residency in radiation oncology and academic faculty assignment at Mansoura University, Egypt. He wanted to advance academically and have access to resources to experience newer technologies and thus he set forth to the United States. Dr. Shabaan pursued multiple research fellowships with an emphasis on combination of immunotherapy and radiation therapy including at MD Anderson Cancer Center. He then achieved successful completion of his second Radiation Oncology residency at University of Minnesota. Following his residency, Dr. Shaaban completed a proton fellowship at Johns Hopkins University.
In addition to his clinical expertise, Dr. Shaaban is conducting innovative clinical trials through the Johns Hopkins Proton Therapy Center. These clinical trials are focused on the use of proton therapy for the treatment of kidney cancer, combination of proton therapy and immunotherapy for the treatment of oligometastatic disease, and optimizing CAR- T cell therapy with bridging radiation therapy. His work seeks to provide more targeted approaches to patient care, limiting adverse side effects and increasing survivability rates.
Research Interests
Combination of Radiation Therapy and Immunotherapy for Treatment of Oligometastatic Disease, Optimizing CAR- T cell Therapy with Bridging Radiation Therapy, Use of Proton Ablative Therapy for Treatment of Kidney Cancer & Use of Radiation Therapy for Treatment of Blood Cancers.
Selected Publications
Sherif G Shaaban, Mohammed K Khan, Natasha Savage, et al.: Total Skin Electron Irradiation (TSEI) May Induce Systemic Progression of Mycosis Fungoides (MF) - Cutaneous T-Cell Lymphoma (CTCL). Dermatol Arch 2018, 2(1):62-67
Sherif G Shaaban, Vivek Verma, Jehee I. Choi, et al: Utilization of Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States. Clinical Lung Cancer 2018, Vol.19, No.5,e 685-e692.
Sherif G. Shaaban, Daniel Ebner and Osama Mohamad: Particle Therapy and Immune System (Ch 11). Principles and Practice of Particle Therapy 2021. Wiley Publishing. https://doi.org/10.1002/9781119707530.ch11
Sherif G. Shaaban, Michael C. LeCompte, Lawrence R. Kleinberg, Kristine J. Redmond and Brandi R. Page: Recognition and Management of the Long-Term Effects of Cranial Radiation. Curr Treat Options Oncol 2023 Jul;24(7):880-891.
James W. Welsh, Chad Tang, Patricia de Groot, Aung Naing, Kenneth R. Hess, John V. Heymach, Vassiliki A. Papadimitrakopoulou, Taylor Cushman, Vivek Subbiah, Joe Y. Chang, George Simon, Erminia Massarelli, Quynh-Nhu Nguyen, Padmanee Sharma, James P. Allison Adi Diab, Vivek Verma, Uma Raju, Sherif G. Shaaban, et al.: Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses. Cancer Immunol Res. 2019; 7(12):1903-1909.
Leslie Chang, Sherif G. Shaaban, Emile Gogineni, Brandi Page, Harry Quon, Heng Li, Rachel Ger Daily Head and Neck Treatment Assessment for Optimal Proton Therapy Planning Robustness. Cancers 2023 Jul 22;15(14):3719.
Steven H. Lin, Kaiping Liao, Xiudong Lei, Vivek Verma, Sherif G. Shaaban, et al: Healthcare Costs Associated with Trimodality Therapy for Esophageal Cancer Using Intensity Modulated Radiation Therapy (IMRT) vs. Proton Beam Therapy (PBT). Int J Part Ther (2022) 9 (1): 18–27
Taylor R Cushman, Sherif G Shaaban, Amy C Moreno, et al.: Management of Unresectable T4b Esophageal Cancer: Practice Patterns and Outcomes from the National Cancer Data Base. Am J Clin Oncol. 2019 Feb;42(2):154-159.
Locations
- The Johns Hopkins Hospital
- 1800 Orleans Street, Baltimore, MD 21287
- phone: 410-955-5000
- fax: 410-955-5001
Expertise
Education
Johns Hopkins University School of Medicine
Fellowship, Radiation Oncology, 2023University of Minnesota Hospital & Clinics
Residency, Radiation Oncology, 2022Mansoura University Hospital
Residency, Radiation Oncology, 2010Mansoura University School of Medicine
Graduate School, Nuclear Oncology, MSc, 2010Mansoura University School of Medicine
Medical Education, MBBCh, 2006Board Certifications
Radiation Oncology
American Board of Radiology, 2023Insurance
- Aetna
- CareFirst
- Cigna
- First Health
- Geisinger Health Plan
- HealthSmart/Accel
- Humana
- Johns Hopkins Health Plans
- MultiPlan
- Pennsylvania's Preferred Health Networks (PPHN)
- Point Comfort Underwriters
- Private Healthcare Systems (PHCS)
- UnitedHealthcare
- Veteran Affairs Community Care Network (Optum-VACCN)